Is there an actuary in the house? Assessing disease management
By Catherine M. Murphy-Barron and Robert Parke
01 August 2004
Escalating healthcare costs are causing employers and insurers to reassess the value and effectiveness of their medical management programs. Many of them are looking at disease management (DM) programs to prevent major disease events and thus reduce the need for and costs of medical care. In this article the authors look at the value of these programs and how to determine the return on your investment.
Read or print the article
About the Author(s)
Robert Parke
Is there an actuary in the house? Assessing disease management
Escalating healthcare costs are causing employers and insurers to reassess the value and effectiveness of their medical management programs. Many of them are looking at disease management (DM) programs to prevent major disease events and thus reduce the need for
Catherine Murphy-Barron, Robert Parke